Praxis Precision Medicines, Inc. (PRAX) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
PRAX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PRAX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | -1682.0% | -2340.3% | -2137.5% |
| 2023 | -3445.8% | -5164.4% | -5037.9% |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export PRAX earnings history in CSV or JSON format
Free sign-in required to download data
Praxis Precision Medicines, Inc. (PRAX) Earnings Overview
As of May 8, 2026, Praxis Precision Medicines, Inc. (PRAX) reported trailing twelve-month net income of -$327M, reflecting -32.0% year-over-year growth. The company earned $-11.31 per diluted share over the past four quarters.
Looking at the long-term picture, PRAX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$27M in fiscal 2018.
Praxis Precision Medicines, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACAD ($376M net income, 36.5% margin), NRIX (-$264M net income, -314.9% margin), ARVN (-$81M net income, -30.8% margin), PRAX has comparable earnings metrics. Compare PRAX vs ACAD →
PRAX Earnings vs Peers
Earnings metrics vs comparable public companies
PRAX Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$303M | -65.9% | -$326M | $-13.48 | - | - |
| 2024 | -$183M | -48.3% | -$200M | $-10.21 | -2137.5% | -2340.3% |
| 2023 | -$123M | +42.4% | -$126M | $-18.69 | -5037.9% | -5164.4% |
| 2022 | -$214M | -28.1% | -$215M | $-69.33 | - | - |
| 2021 | -$167M | -170.2% | -$167M | $-58.96 | - | - |
| 2020 | -$62M | -74.1% | -$62M | $-103.61 | - | - |
| 2019 | -$36M | -33.8% | -$36M | $-348.24 | - | - |
| 2018 | -$27M | - | -$23M | $-306.73 | - | - |
Full PRAX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See PRAX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRAX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRAX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRAX — Frequently Asked Questions
Quick answers to the most common questions about buying PRAX stock.
Is PRAX growing earnings?
PRAX EPS fell to $-11.31, with earnings declining -32.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-327M.
What are PRAX's profit margins?
Praxis Precision Medicines, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are PRAX's earnings?
PRAX earnings data spans 2018-2025. The declining earnings trend is -32.0% YoY. Historical data enables comparison across business cycles.